Inspire Medical Systems, Inc , a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally.
infoInspire Medical Systems is a mid cap stock with a total market cap of 6.16B.
infoThey trade on the NYSE and had their IPO 5 years and 3 months ago.
infoInspire Medical Systems currently employs 755 people.
infoAs of Wednesday, Aug 23 2023, Inspire Medical Systems’s share price is $211.28.
News Relating to Inspire Medical Systems
GlobeNewsWire
Inspire Medical Systems, Inc. to Present at the Wells Fargo 2023 Healthcare Conference
Wednesday Aug 23 2023 at 08:00
MINNEAPOLIS, Aug. 23, 2023 (GLOBE NEWSWIRE) — Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire), a medical technology company focused on the development and commercialization of innovative, minimally invasive solutions for patients with obstructive sleep apnea, announced today that its management team will present at the Wells Fargo 2023 Healthcare Conference on Wednesday, September 6, 2023.
Seeking Alpha
Inspire Medical Systems: Excellent Execution And Reset Valuation
Wednesday Aug 16 2023 at 20:31
Inspire Medical Systems has performed well in 2023 with its hyperglossal nerve stimulation design for sleep apnea sufferers. The company plans to release a version without a sensor lead in 2024, making the procedure even easier for physicians. Inspire is focused on creating high-quality software to improve the user experience and compete with cumbersome masks.
Zacks Investment Research
Inspire Medical (INSP) Q2 Earnings & Revenues Top Estimates
Wednesday Aug 02 2023 at 12:42
Inspire Medical’s (INSP) both geographic regions witness strong revenue growth in the second quarter.
Seeking Alpha
Inspire Medical Systems, Inc. (INSP) Q2 2023 Earnings Call Transcript
Wednesday Aug 02 2023 at 01:04
Inspire Medical Systems, Inc. (NYSE:INSP ) Q2 2023 Earnings Conference Call August 1, 2023 5:00 PM ET Company Participants Ezgi Yagci – Vice President of Investor Relations Tim Herbert – President & Chief Executive Officer Rick Buchholz – Chief Financial Officer Conference Call Participants John Block – Stifel Robbie Marcus – JPMorgan Travis Steed – Bank of America Adam Maeder – Piper Sandler Richard Newitter – Truist Securities Lei Huang – Wells Fargo Anthony Petrone – Mizuho Americas David Rescott – Baird Matthew Mishan – KeyBanc Suraj Kalia – Oppenheimer & Co. Operator Good afternoon. My name is Dilem [ph], and I’ll be your conference operator today.
Zacks Investment Research
Compared to Estimates, Inspire (INSP) Q2 Earnings: A Look at Key Metrics
Tuesday Aug 01 2023 at 20:56
While the top- and bottom-line numbers for Inspire (INSP) give a sense of how the business performed in the quarter ended June 2023, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
Zacks Investment Research
Inspire Medical Systems (INSP) Reports Q2 Loss, Tops Revenue Estimates
Tuesday Aug 01 2023 at 18:40
Inspire Medical Systems (INSP) came out with a quarterly loss of $0.41 per share versus the Zacks Consensus Estimate of a loss of $0.51. This compares to loss of $0.53 per share a year ago.
Seeking Alpha
Inspire Medical Systems: Revolutionizing Obstructive Sleep Apnea Treatment
Wednesday Jul 19 2023 at 14:17
Inspire Medical Systems has reported a significant 84% rise in Q1 2023 revenue, reaching $127.9 million, driven by its innovative treatments for Obstructive Sleep Apnea. The company has received FDA clearance for expanded indications of its Inspire therapy, broadening the range of patients who can access the treatment. Despite facing competition and adoption challenges, Inspire’s financial strength, innovative product pipeline, and recent successes position it as a compelling investment opportunity in the OSA market.
MarketBeat
Inspire Medical Up 15% After Breakout, Analysts Say It’s A Buy
Thursday Jul 06 2023 at 08:26
Inspire Medical Systems NYSE: INSP is up nearly 15% since breaking out of cup-with-handle base on May 3. The base’s buy point was above $277.18, which you can see on the Inspire Medical Systems chart.
GlobeNewsWire
Inspire Medical Systems, Inc. to Report Second Quarter 2023 Financial Results on August 1, 2023
Wednesday Jul 05 2023 at 08:00
MINNEAPOLIS, July 05, 2023 (GLOBE NEWSWIRE) — Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire) will release financial results for the second quarter 2023 after the close of trading on Tuesday, August 1. Inspire’s management team will host a corresponding conference call beginning at 5:00 p.m. Eastern Time to discuss the financial results and recent business developments.
Zacks Investment Research
Inspire Medical (INSP) Hits 52-Week High: What’s Aiding It?
Monday Jun 26 2023 at 12:01
Investors are optimistic about Inspire Medical’s (INSP) global presence.
InvestorPlace
7 Healthcare Stocks to Make You the Millionaire Next Door
Wednesday Jun 21 2023 at 20:41
Investing in healthcare stocks can be a wise decision for those looking to become wealthy in the long term. Some of the best healthcare stocks to buy are firms that are developing highly effective drugs for prevalent diseases for which there are no real effective treatments.
Seeking Alpha
Inspire Medical Systems: Valuation, Sentiment, Fundamental Factors Call For Re-Rating
Wednesday Jun 14 2023 at 22:30
Inspire Medical has multiple catalysts in the pipeline that could see it attract investment. These center around fundamental, sentimental and valuation factors. The company could be fairly valued at $317/share, indicating potential mispricing.
Zacks Investment Research
Inspire (INSP) Gets FDA Nod for Expanded Indication of AHI
Monday Jun 12 2023 at 10:28
The FDA approves Inspire’s (INSP) application to expand the indication to include patients with AHI up to 100 events per hour.
Zacks Investment Research
3 Reasons to Hold Inspire Medical (INSP) Stock in Your Portfolio
Monday May 22 2023 at 12:50
Investors continue to be optimistic about Inspire Medical (INSP) on the back of its product innovations.
GlobeNewsWire
UPDATE – Inspire Medical Systems, Inc. to Present at the BofA Securities Health Care Conference 2023
Wednesday May 03 2023 at 08:00
MINNEAPOLIS, May 03, 2023 (GLOBE NEWSWIRE) — Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire), a medical technology company focused on the development and commercialization of innovative, minimally invasive solutions for patients with obstructive sleep apnea, announced today that its management team will present at the BofA Securities Health Care Conference 2023 on Wednesday, May 10, 2023.
Seeking Alpha
Inspire Medical Systems, Inc. (INSP) Q1 2023 Earnings Call Transcript
Wednesday May 03 2023 at 00:55
Inspire Medical Systems, Inc. (NYSE:INSP ) Q1 2023 Earnings Conference Call May 2, 2023 5:00 PM ET Company Participants Ezgi Yagci – Vice President of Investor Relations Tim Herbert – President & Chief Executive Officer Rick Buchholz – Chief Financial Officer Conference Call Participants Robbie Marcus – JPMorgan Larry Biegelsen – Wells Fargo Travis Steed – Bank of America John Block – Stifel Adam Maeder – Piper Sandler Rich Newitter – Truist Chris Pasquale – Nephron Research Matthew Mishan – KeyBanc Anthony Petrone – Mizuho Security Suraj Kalia – Oppenheimer Michael Polark – Wolfe Research Operator Good afternoon. My name is Del [ph] and I’ll be your conference operator today.
Zacks Investment Research
Inspire Medical Systems (INSP) Reports Q1 Loss, Tops Revenue Estimates
Tuesday May 02 2023 at 18:23
Inspire Medical Systems (INSP) came out with a quarterly loss of $0.53 per share versus the Zacks Consensus Estimate of a loss of $0.70. This compares to loss of $0.61 per share a year ago.
GlobeNewsWire
Inspire Medical Systems, Inc. to Present at the BofA Securities Health Care Conference 2023
Wednesday Apr 26 2023 at 08:00
MINNEAPOLIS, April 26, 2023 (GLOBE NEWSWIRE) — Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire), a medical technology company focused on the development and commercialization of innovative, minimally invasive solutions for patients with obstructive sleep apnea, announced today that its management team will present at the BofA Securities Health Care Conference 2023 on Wednesday, May 10, 2023.
Investors Business Daily
Don’t Sleep On This Growth Stock: Soaring Sales Make Up For Inspire’s Losses
Monday Apr 24 2023 at 13:57
Growth stock Inspire Medical has strong sales growth since its IPO. The stock is near a buy point with earnings due.
Zacks Investment Research
What Makes Inspire (INSP) a New Buy Stock
Thursday Apr 13 2023 at 13:39
Inspire (INSP) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company’s earnings prospects. This might drive the stock higher in the near term.
Zacks Investment Research
3 Medical Info Systems Stocks Countering Industry-wide Headwinds
Tuesday Apr 04 2023 at 12:56
Zacks Medical Info Systems industry stocks like Inspire Medical Systems (INSP), Olink Holding (OLK) and Health Catalyst (HCAT) are expected to gain even as COVID-19 severity fades.
GlobeNewsWire
Inspire Medical Systems, Inc. to Report First Quarter 2023 Financial Results on May 2, 2023
Tuesday Apr 04 2023 at 08:00
MINNEAPOLIS, April 04, 2023 (GLOBE NEWSWIRE) — Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire) will release financial results for the first quarter 2023 after the close of trading on Tuesday, May 2. Inspire’s management team will host a corresponding conference call beginning at 5:00 p.m. Eastern Time to discuss the financial results and recent business developments.
Seeking Alpha
Inspire Medical Systems: Sleep Apnea Equipment Specialist Looks Like A Buy
Sunday Mar 26 2023 at 01:54
These articles are intended to provide readers with equity investment subjects [stocks, ETFs, REITs] likely to experience rising market prices in the next 3-5 months: Near-term expectations only. Histories of their prior expectations — like today’s for INSP coming price outcomes — are presented for stocks frequently Yahoo-sourced by investors at the same time.
InvestorPlace
7 Healthcare Stocks to Buy for Long-Term Growth and Stability
Tuesday Mar 21 2023 at 16:13
Stock market investors have been on a rollercoaster ride over the past year. The Federal Reserve continues to be hawkish in controlling inflation.
GlobeNewsWire
Inspire Medical Systems, Inc. to Present at the KeyBanc Capital Markets Life Sciences & MedTech Investor Forum
Tuesday Mar 07 2023 at 08:00
MINNEAPOLIS, March 07, 2023 (GLOBE NEWSWIRE) — Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire), a medical technology company focused on the development and commercialization of innovative, minimally invasive solutions for patients with obstructive sleep apnea, announced today that its management team will present at the virtual KeyBanc Capital Markets Life Sciences & MedTech Investor Forum on Tuesday, March 21, 2023.
Zacks Investment Research
New Strong Buy Stocks for February 21st
Tuesday Feb 21 2023 at 09:02
EMBC, INSP, REPYY, BZLFY and CVI have been added to the Zacks Rank #1 (Strong Buy) List on February 21, 2023.
Zacks Investment Research
New Strong Buy Stocks for February 17th
Friday Feb 17 2023 at 08:17
KNBWY, INSP, HLF, VTNR and HBT have been added to the Zacks Rank #1 (Strong Buy) List on February 17, 2023.
Zacks Investment Research
New Strong Buy Stocks for February 14th
Tuesday Feb 14 2023 at 09:02
INSP, ALK, SSKN, NVO and TBPH have been added to the Zacks Rank #1 (Strong Buy) List on February 14, 2023.
Investors Business Daily
INSP Stock Breaks Out On Massive Sales Growth
Wednesday Feb 08 2023 at 12:58
Inspire is Wednesday’s IBD Stock Of The Day. The sleep apnea expert reported massive sales growth, leading shares to break out.
Seeking Alpha
Inspire Medical Systems, Inc. (INSP) Q4 2022 Earnings Call Transcript
Tuesday Feb 07 2023 at 21:12
Inspire Medical Systems, Inc. (NYSE:INSP ) Q4 2022 Results Conference Call February 7, 2023 5:00 PM ET Company Participants Ezgi Yagci – Vice President of Investor Relations Tim Herbert – President & Chief Executive Officer Rick Buchholz – Chief Financial Officer Conference Call Participants Travis Steed – Bank of America Robbie Marcus – JPMorgan Adam Maeder – Piper Sandler Rich Newitter – Truist Larry Biegelsen – Wells Fargo John Block – Stifel Michael Polark – Wolfe Research Chris Pasquale – Nephron Research Matthew Mishan – KeyBanc Suraj Kalia – Oppenheimer Operator Good afternoon. My name is Josh, and I’ll be your conference operator today.
Inspire Medical Systems Bankruptcy Risk
The Altman Z-score is a formula that measures a company’s financial health and bankruptcy risk. It assigns a numerical score based on various financial ratios. The Z-score is divided into different zones. If the Z-score is above 2.99, it indicates a lower bankruptcy risk, classifying the company as ‘safe’ or ‘non-distressed’. If the score falls below 1.81, it suggests a higher risk, indicating potential financial distress or bankruptcy. The range between 1.81 and 2.99 is called the ‘gray zone’ or zone of ambiguity.
Learn more at Investopediaopen_in_new
Inspire Medical Systems’s Altman Z-score is 42.33 which is in the safe zone. This indicates the company is financially stable and less likely to experience financial distress or bankruptcy.
Derived from SEC.GOV filing dataopen_in_new
Inspire Medical Systems Insider Trading
Insider trading is when individuals employed by a company buy or sell its securities following legal procedures and regulations. Company executives, directors, and employees may be permitted to buy or sell shares if they follow specific rules, such as filing a Form 4 with the SEC within two business days.
Learn more at Investopediaopen_in_new
Over the last 3 months, 1 insider has sold $153.66K of common stock in Inspire Medical Systems on the stock market with no insider buying.
Derived from SEC.GOV filing dataopen_in_new
Debt & Income Analysis
Income quality measures a company’s operating cash flow to net income ratio. It helps investors and analysts assess the sustainability of a company’s earnings. A high QIR indicates strong cash flows, while a low QIR may indicate non-operating activities driving net income.
Learn more at WallStreetPrepopen_in_new
Inspire Medical Systems’s Income Quality of -0.56 is lower than its Industry Group of 0.68 (-182.4% lower)
Inspire Medical Systems’s Income Quality of -0.56 is lower than its Major Industry Group of 0.71 (-178.9% lower)
Inspire Medical Systems’s Income Quality of -0.56 is lower than its Sector of 0.75 (-174.7% lower)
Derived from SEC.GOV filing dataopen_in_new
Current ratio measures a company’s ability to pay off short-term debt with its current assets (assets that a company expects to use up or convert to cash within a year). It represents the $ amount of current assets a company has for every $1 of short-term debt. A high current ratio above 1.0 indicates that a company can meet its short-term obligations, while a low current ratio below 1.0 suggests difficulty.
Learn more at Investopediaopen_in_new
Inspire Medical Systems’s Current Ratio of 8.4 is greater than its Industry Group of 3.36 (150.0% greater)
Inspire Medical Systems’s Current Ratio of 8.4 is greater than its Major Industry Group of 3.13 (168.4% greater)
Inspire Medical Systems’s Current Ratio of 8.4 is greater than its Sector of 2.6 (223.1% greater)
Derived from SEC.GOV filing dataopen_in_new
Value Analysis
PE ratio (price-to-earnings), measures a company’s stock price relative to its earnings per share. It helps investors evaluate whether its stock is overvalued or undervalued. A higher PE ratio indicates that investors are willing to pay more for a company’s earnings, while a lower PE ratio (above zero) suggests the company could be undervalued.
Learn more at Investopediaopen_in_new
Cannot compare a negative PE Ratio (-150.06 & -1.02)
Cannot compare a negative PE Ratio (-150.06 & -0.58)
Cannot compare a negative PE Ratio (-150.06 & -0.4)
Derived from SEC.GOV filing dataopen_in_new
The PB ratio (price-to-book), measures a company’s stock price relative to its book value (net value of a company’s assets reported on its balance sheet, after subtracting debt) per share. It is used to evaluate a company’s valuation, with a lower PB ratio (above zero) indicating a lower valuation and a higher PB ratio suggesting overvaluation.
Learn more at Investopediaopen_in_new
Inspire Medical Systems’s PB Ratio of 11.64 is greater than its Industry Group of 1.9 (512.6% greater)
Inspire Medical Systems’s PB Ratio of 11.64 is greater than its Major Industry Group of 1.93 (503.1% greater)
Inspire Medical Systems’s PB Ratio of 11.64 is greater than its Sector of 1.62 (618.5% greater)
Derived from SEC.GOV filing dataopen_in_new
Efficiency Analysis
ROE (Return on Equity), is a financial ratio that measures a company’s profitability relative to its shareholders’ equity (the amount of value in a company that belongs to the people who own shares). It indicates how efficiently a company generates profits per unit of equity invested. A high ROE suggests effective use of equity, while a low ROE indicates inefficiency.
Learn more at Investopediaopen_in_new
Inspire Medical Systems’s ROE of -0.08 is greater than its Industry Group of -0.26 (69.2% greater)
Inspire Medical Systems’s ROE of -0.08 is greater than its Major Industry Group of -0.09 (11.1% greater)
Inspire Medical Systems’s ROE of -0.08 is lower than its Sector of -0.03 (-166.7% lower)
Derived from SEC.GOV filing dataopen_in_new
ROCE (Return on Capital Employed), is a financial ratio that measures a company’s profitability relative to the amount of capital invested in its operations. It indicates how well a company is generating profits from its capital investments. A high ROCE suggests effective use of capital, while a low ROCE indicates inefficiency.
Learn more at Investopediaopen_in_new
Inspire Medical Systems’s ROCE of -0.09 is greater than its Industry Group of -0.27 (66.7% greater)
Inspire Medical Systems’s ROCE of -0.09 is greater than its Major Industry Group of -0.14 (35.7% greater)
Inspire Medical Systems’s ROCE of -0.09 is lower than its Sector of -0.04 (-125.0% lower)
Derived from SEC.GOV filing dataopen_in_new